Company Filing History:
Years Active: 2015-2017
Title: The Innovative Contributions of Li Shan
Introduction
Li Shan is a prominent inventor based in Laval, Canada. She has made significant strides in the field of biotechnology, particularly in the treatment of viral infections. With a total of 3 patents to her name, her work is paving the way for new therapeutic approaches.
Latest Patents
Li Shan's latest patents focus on the treatment of hepatitis B virus (HBV) infection. One of her inventions is directed to an RNA interference (RNAi) agent that is utilized to treat hepatitis B infection in individuals. This invention includes pharmaceutical compositions containing the RNAi agents, which inhibit the expression of at least one HBV gene. The RNAi agents comprise effector sequences that are complementary to a predicted sequence transcribed from a target region. In some forms of her invention, the agents have multiple effector sequences that may target the same region of an HBV gene, different regions of the same gene, or different HBV genes.
Career Highlights
Li Shan is currently associated with Benitec Biopharma Limited, where she continues to innovate in the field of RNAi technology. Her work is crucial in developing effective treatments for viral infections, showcasing her commitment to advancing medical science.
Collaborations
Li Shan collaborates with notable colleagues, including Michael Wayne Graham and Peter French. These partnerships enhance her research and contribute to the development of groundbreaking therapies.
Conclusion
Li Shan's contributions to the field of biotechnology, particularly in the treatment of hepatitis B, highlight her innovative spirit and dedication to improving healthcare. Her patents represent significant advancements that could change the landscape of viral infection treatment.